| Dr Aaron E Hagge-greenberg, MD | |
|
170 Maple Ave, Suite 104, White Plains, NY 10601-4710 | |
| (914) 949-7556 | |
| Not Available |
| Full Name | Dr Aaron E Hagge-greenberg |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 18 Years |
| Location | 170 Maple Ave, White Plains, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952666877 | NPI | - | NPPES |
| 03886697 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 265619 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| White Plains Hospital Center | White plains, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| White Plains Physician Services Pc | 3476894445 | 304 |
News Archive
The development of simple tests to predict a leukemic relapse in young patients is a step closer thanks to researchers from the Sainte-Justine University Hospital Research Center and the University of Montreal. Approximately 20 percent of young leukemia patients who are treated with stem cells derived from umbilical cord blood will experience leukemic relapse.
A new study in The Journal of Pain, published by the American Pain Society, www.ampainsoc.org, shows that changes in pain severity can predict subsequent depression severity and, likewise, a worsening change in depression is an equally strong predictor of subsequent pain severity.
Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population.
Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.
AccuVein Inc., the global leader in vein illumination and the creator of the AV300, the world's only hand-held, non-contact vein illumination device, today reported the findings of its study on the impact that vein illumination has on patient preference and overall satisfaction.
› Verified 3 days ago
| Entity Name | Metropolitan Lithotriptor Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891027967 PECOS PAC ID: 5193615730 Enrollment ID: O20040317001512 |
News Archive
The development of simple tests to predict a leukemic relapse in young patients is a step closer thanks to researchers from the Sainte-Justine University Hospital Research Center and the University of Montreal. Approximately 20 percent of young leukemia patients who are treated with stem cells derived from umbilical cord blood will experience leukemic relapse.
A new study in The Journal of Pain, published by the American Pain Society, www.ampainsoc.org, shows that changes in pain severity can predict subsequent depression severity and, likewise, a worsening change in depression is an equally strong predictor of subsequent pain severity.
Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population.
Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.
AccuVein Inc., the global leader in vein illumination and the creator of the AV300, the world's only hand-held, non-contact vein illumination device, today reported the findings of its study on the impact that vein illumination has on patient preference and overall satisfaction.
› Verified 3 days ago
| Entity Name | Middletown Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902855828 PECOS PAC ID: 2567464308 Enrollment ID: O20070208000144 |
News Archive
The development of simple tests to predict a leukemic relapse in young patients is a step closer thanks to researchers from the Sainte-Justine University Hospital Research Center and the University of Montreal. Approximately 20 percent of young leukemia patients who are treated with stem cells derived from umbilical cord blood will experience leukemic relapse.
A new study in The Journal of Pain, published by the American Pain Society, www.ampainsoc.org, shows that changes in pain severity can predict subsequent depression severity and, likewise, a worsening change in depression is an equally strong predictor of subsequent pain severity.
Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population.
Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.
AccuVein Inc., the global leader in vein illumination and the creator of the AV300, the world's only hand-held, non-contact vein illumination device, today reported the findings of its study on the impact that vein illumination has on patient preference and overall satisfaction.
› Verified 3 days ago
| Entity Name | White Plains Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124502687 PECOS PAC ID: 3476894445 Enrollment ID: O20190402000216 |
News Archive
The development of simple tests to predict a leukemic relapse in young patients is a step closer thanks to researchers from the Sainte-Justine University Hospital Research Center and the University of Montreal. Approximately 20 percent of young leukemia patients who are treated with stem cells derived from umbilical cord blood will experience leukemic relapse.
A new study in The Journal of Pain, published by the American Pain Society, www.ampainsoc.org, shows that changes in pain severity can predict subsequent depression severity and, likewise, a worsening change in depression is an equally strong predictor of subsequent pain severity.
Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population.
Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.
AccuVein Inc., the global leader in vein illumination and the creator of the AV300, the world's only hand-held, non-contact vein illumination device, today reported the findings of its study on the impact that vein illumination has on patient preference and overall satisfaction.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron E Hagge-greenberg, MD 532 Broadhollow Rd, Suite 142, Melville, NY 11747-3672 Ph: (516) 931-0041 | Dr Aaron E Hagge-greenberg, MD 170 Maple Ave, Suite 104, White Plains, NY 10601-4710 Ph: (914) 949-7556 |
News Archive
The development of simple tests to predict a leukemic relapse in young patients is a step closer thanks to researchers from the Sainte-Justine University Hospital Research Center and the University of Montreal. Approximately 20 percent of young leukemia patients who are treated with stem cells derived from umbilical cord blood will experience leukemic relapse.
A new study in The Journal of Pain, published by the American Pain Society, www.ampainsoc.org, shows that changes in pain severity can predict subsequent depression severity and, likewise, a worsening change in depression is an equally strong predictor of subsequent pain severity.
Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population.
Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.
AccuVein Inc., the global leader in vein illumination and the creator of the AV300, the world's only hand-held, non-contact vein illumination device, today reported the findings of its study on the impact that vein illumination has on patient preference and overall satisfaction.
› Verified 3 days ago
George F. Owens, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 311 North St, Suite 201, White Plains, NY 10605 Phone: 914-946-1406 | |
Dr. Bryan Paul Blair, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-682-6470 Fax: 914-681-5245 | |
Sol M Usher, MD Urology Medicare: Medicare Enrolled Practice Location: 12 Greenridge Avenue, White Plains, NY 10605 Phone: 914-682-7477 | |
Seth Edward Lerner, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 170 Maple Ave, White Plains, NY 10601 Phone: 914-949-7556 | |
Dr. David Joel Narins, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 222 Westchester Ave, White Plains, NY 10604 Phone: 718-684-1122 | |
Dr. Barry Scott Kimmel, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-682-6470 Fax: 914-681-6264 | |
Charles Norman Glassman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 170 Maple Ave, Suite 104, White Plains, NY 10601 Phone: 914-949-7556 Fax: 914-949-5024 |